Cardiovascular Disease: Why Engaging Patients is Essential to Improving Outcomes
Engaged individuals empowered with technology have been transforming every industry for some time. Health care has lagged behind this revolution, but it is catching up. Considering the prevalence and impact of heart disease and stroke, technology that empowers this patient population to achieve healthier lifestyles and better medication adherence should be among the highest priorities for health systems in the US and Canada. The return for healthcare stakeholders is significant.
Empowering patients with cardiovascular disease (CVD) helps providers deliver better care, and lowers costs for payers. Pharmaceutical manufacturers that sponsor patient empowerment can grow revenues and their business when people take their medicine. And pharmacy retailers that invest in empowering patients can build customer loyalty and repeat store visits.